(Q37980482)

26 August 2017

Ewing sarcoma: clinical state-of-the-art (English)

1 reference

26 August 2017

Jenny Potratz

1

1 reference

26 August 2017

Uta Dirksen

series ordinal

2

1 reference

26 August 2017

Heribert Jürgens

series ordinal

3

1 reference

26 August 2017

Alan Craft

series ordinal

4

1 reference

26 August 2017

1 February 2012

1 reference

Pediatric Hematology and Oncology

26 August 2017

1 reference

26 August 2017

29

1 reference

26 August 2017

1-11

1 reference

26 August 2017

1

1 reference

Ewing's sarcoma family of tumors: current management

26 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Ethnic and racial differences in patients with Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Clinical features and outcomes in patients with extraskeletal Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

The immunophenotype of Ewing's sarcoma. An immunohistochemical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

EWS-ETS oncoproteins: the linchpins of Ewing tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT-PCR: a preliminary evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Impact of EWS-ETS fusion type on disease progression in Ewing's sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Prognostic impact of chromosomal aberrations in Ewing tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Integrated therapy for Ewing's sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Curability of ewing's sarcoma and considerations for future therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Survival after recurrence of Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2011.622034

10.3109/08880018.2011.622034

21 January 2018

Identifiers

DOI

1 reference

release_pmknq35z35dbvk4lxprvzjelay

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pmknq35z35dbvk4lxprvzjelay

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference